Serum Institute to resume supply of Covishield to COVAX: Reports

Published on Nov 23, 2021 11:27 AM IST

In April, the Centre halted supply of Covid-19 vaccines to the UN-backed programme as India itself was hit by a severe second wave of the pandemic.

Adar Poonawalla, chief executive officer of Serum Institute of India. (File photo)
Adar Poonawalla, chief executive officer of Serum Institute of India. (File photo)
By, New Delhi

Adar Poonawalla's Serum Institute of India, the world's largest vaccine manufacturer, will, according to reports, soon resume its supply of Covishield, the vaccine against the coronavirus disease (Covid-19), under the COVAX programme. 

Also Read | Negotiations over release of vaccine for Covax in final stage

According to a recent report, the Union government has allowed the SII to export 5 million doses of Covishield under COVAX, which is backed by the United Nations, to Nepal, Bangladesh, Tajikistan and Mozambique. Nepal was scheduled to receive the first batch, on November 24. The delivery has, however, been delayed.

“The first consignment from the main Pune facility was scheduled to leave for Nepal today. However, the delivery has been delayed by two-three days due to some reason. The exact date of the consignment dispatch is still awaited,” news agency ANI quoted a Serum Institute official as saying, on Monday.

In April this year, the Centre halted the export of Covid-19 vaccines as a severe second wave hit the country. However, with the second wave now under control, the supply to COVAX was expected to restart soon.

Also Read | COVAX supply likely to resume this month

Covishield is the Indian variant of Britain's Oxford University-AstraZeneca jab, and is manufactured by the SII under that name in India. It is one of the two most widely-used jabs in the country, with the other being Covaxin, developed by the Hyderabad-based Bharat Biotech International Limited. Covishield and Covaxin were the first two shots to receive emergency use authorisation (EUA) in India for the vaccination drive, which began on January 16.

Also Read | Vaccine hesitancy now greatest threat in overcoming pandemic: SII's Poonawalla

COVAX, meanwhile, stands for ‘Covid-19 Vaccines Global Access.’ It is co-led by Gavi, World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI). The initiative enables access to coronavirus vaccines, tests and therapies for low-to-middle income countries.



Get Latest India Newsalong with Latest Newsand Top Headlinesfrom India and around the world.
Story Saved
Saved Articles
My Reads
My Offers
Sign out
New Delhi 0C
Monday, November 28, 2022
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals